SCHEMBL46315

SCHEMBL46315

Cc1cnc2c(c1)CCC(=O)N2C

nearest known ligand 0.50

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 13/20 0.50
BMPR1B O00238 1/20 0.48
BMPR1A P36894 1/20 0.48
ACVRL1 P37023 1/20 0.48
ACVR1 Q04771 1/20 0.48
SRD5A1 P18405 5/20 0.44
CYP11B1 P15538 9/20 0.38
CYP19A1 P11511 3/20 0.38
CYP1A2 P05177 2/20 0.38
CYP17A1 P05093 1/20 0.38
SRD5A2 P31213 1/20 0.34
CYP3A4 P08684 2/20 0.34
HTR1A P08908 1/20 0.33
DRD2 P14416 1/20 0.33
HTR2A P28223 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8629038 0.84 CYP11B2 (0.36) CYP11B2BMPR1BBMPR1AACVRL1ACVR1
SCHEMBL2051397 0.81 BMPR1B (0.50) CYP11B2BMPR1BBMPR1AACVRL1ACVR1
SCHEMBL25921027 0.81 CYP11B2 (0.49) CYP11B2BMPR1BBMPR1AACVRL1ACVR1
SCHEMBL30404193 0.81 BMPR1B (0.50) CYP11B2BMPR1BBMPR1AACVRL1ACVR1
SCHEMBL31178367 0.81 CYP11B2 (0.49) CYP11B2BMPR1BBMPR1AACVRL1ACVR1
SCHEMBL25317019 0.81 CYP11B2 (0.49) CYP11B2BMPR1BBMPR1AACVRL1ACVR1
SCHEMBL21831983 0.81 CYP11B2 (0.49) CYP11B2BMPR1BBMPR1AACVRL1ACVR1
SCHEMBL9836345 0.79 CYP11B2 (0.47) CYP11B2BMPR1BBMPR1AACVRL1ACVR1
SCHEMBL26023601 0.79 CYP11B2 (0.34) CYP11B2BMPR1BBMPR1AACVRL1ACVR1
SCHEMBL26023616 0.75 CYP11B2 (0.32) CYP11B2BMPR1BBMPR1AACVRL1ACVR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011151436-A2 NOVEL COMPOUNDS, METHOD FOR USE THEM AND PHARMACEUTICAL COMPOSITION CONTAINING THEM EUROSCREEN S.A. (BE) 2011-12-08 WO disclosed